Chiyi Jiang
Beijing Key Laboratory For Pediatric Diseases Of Otolaryngology, Head And Neck Surgery, MOE Key Laboratory Of Major Diseases In Children
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Impact of the COVID-19 pandemic on the demographic and disease burden of pediatric malignant solid tumors in China: a single-center, cross-sectional study.
Journal: Translational pediatrics
Published: September 14, 2023
Nectin2 influences cell apoptosis by regulating ANXA2 expression in neuroblastoma.
Journal: Acta biochimica et biophysica Sinica
Published: March 14, 2023
Hepatoblastoma with neonatal necrotizing enterocolitis: Two case reports.
Journal: Cancer innovation
Published: February 14, 2023
BPTF in bone marrow provides a potential progression biomarker regulated by TFAP4 through the PI3K/AKT pathway in neuroblastoma.
Journal: Biological procedures online
Published: December 31, 2022
Quantitative proteomics identifies and validates urinary biomarkers of rhabdomyosarcoma in children.
Quantitative proteomics identifies and validates urinary biomarkers of rhabdomyosarcoma in children.
Journal: Clinical proteomics
Published: December 01, 2022
Economic burden for retinoblastoma patients in China.
Journal: Journal of medical economics
Published: October 01, 2020
Analysis of treatment cost for neuroblastoma to the family: a single-center cross-sectional study in China.
Journal: Journal of medical economics
Published: June 23, 2020
The development and initial evaluation of referral flowchart for suspected neuroblastoma for pediatricians in nononcology clinics in China.
Journal: Pediatric blood & cancer
Published: December 19, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026